Google DeepMind cofounder and CEO Demis Hassabis and John Jumper, a senior researcher at the company, shared the 2024 Nobel Prize for Chemistry for their work on AlphaFold, an AI model that predicts ...

Join the event trusted by enterprise leaders for nearly two decades. VB Transform brings together the people building real enterprise AI strategy. Learn more Google DeepMind and Isomorphic Labs today ...

In the rapidly evolving world of science and medicine, artificial intelligence (AI) is playing an increasingly pivotal role. Google DeepMind’s AlphaFold 3 stands at the forefront of this AI revolution ...

The people behind the original protein modeling tool Alphafold have now developed a newer version, Alphafold 3, which is changing the way that this fundamental technology works. Looking at the changes ...

Google DeepMind has unexpectedly released the source code and model weights of AlphaFold 3 for academic use, marking a significant advance that could accelerate scientific discovery and drug ...

Mapping proteins unlocks clues to preventing and treating illnesses. Here’s how DeepMind’s AlphaFold is accelerating this research exponentially.

TORONTO, ON – New research uses AlphaFold, an artificial intelligence (AI)-powered protein structure database, to accelerate the design and synthesis of a drug to treat hepatocellular carcinoma (HCC), ...

Insilico Medicine (“Insilico”), a clinical-stage end-to-end generative artificial intelligence (AI) drug discovery company, has achieved a significant breakthrough in the application of multiple ...

Nearly five years ago, DeepMind, one of Google’s more prolific AI-centered research labs, debuted AlphaFold, an AI system that can accurately predict the structures of many proteins inside the human ...

Every two years since 1994, scientists have come together for an experiment — better described as a competition — where teams of computational biologists try to predict what proteins will look like in ...